These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1153135)

  • 1. Micronized 17 beta-estradiol for oral estrogen therapy in menopausal women.
    Callantine MR; Martin PL; Bolding OT; Warner PO; Greaney MO
    Obstet Gynecol; 1975 Jul; 46(1):37-41. PubMed ID: 1153135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone.
    Ferenczy A; Gelfand MM
    Maturitas; 1997 Apr; 26(3):219-26. PubMed ID: 9147354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial 17beta-estradiol dose for treating vasomotor symptoms.
    Notelovitz M; Lenihan JP; McDermott M; Kerber IJ; Nanavati N; Arce J
    Obstet Gynecol; 2000 May; 95(5):726-31. PubMed ID: 10775738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and local tolerance of a low-dose, 7-day matrix estradiol transdermal system in the treatment of menopausal vasomotor symptoms.
    Speroff L; Whitcomb RW; Kempfert NJ; Boyd RA; Paulissen JB; Rowan JP
    Obstet Gynecol; 1996 Oct; 88(4 Pt 1):587-92. PubMed ID: 8841224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women.
    Dupont A; Dupont P; Cusan L; Tremblay M; Rioux J; Cloutier D; Mailloux J; De Lignières B; Gutkowska J; Boucher H
    Maturitas; 1991 Oct; 13(4):297-311. PubMed ID: 1663571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17 beta-estradiol for postmenopausal estrogen replacement therapy.
    Nichols KC; Schenkel L; Benson H
    Obstet Gynecol Surv; 1984 Apr; 39(4):230-45. PubMed ID: 6717863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose estradiol for climacteric symptoms in Japanese women: a randomized, controlled trial.
    Honjo H; Taketani Y
    Climacteric; 2009 Aug; 12(4):319-28. PubMed ID: 19330598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
    Rohr UD; Volko CD; Schindler AE
    Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy on climacteric symptoms and safety of low dose estradiol transdermal matrix patches. A randomized, double-blind placebo-controlled study.
    De Aloysio D; Rovati LC; Giacovelli G; Setnikar I; Bottiglioni F
    Arzneimittelforschung; 2000 Mar; 50(3):293-300. PubMed ID: 10758784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
    Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
    Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
    Genazzani AR; Cappagli B; Ciaponi M
    Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women.
    Darj E; Nilsson S; Axelsson O; Hellberg D
    Maturitas; 1991 Jun; 13(2):109-15. PubMed ID: 1921733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation, dose-finding and acceptability of AERODIOL, the pulsed estrogen therapy for treatment of climacteric symptoms.
    Pelissier C; de Kervasdoue A; Chuong VT; Maugis EL; de Mouillac F; Breil MH; Moniot G; Zeitoun-Lepvrier G; Robin M; Rime B
    Maturitas; 2001 Jan; 37(3):181-9. PubMed ID: 11173180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.